Category: ‘Clinical Trials and Studies’
Posted on September 20th, 2023
Billionaire entrepreneur Elon Musk’s brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.
Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said, but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete.
Posted on April 13th, 2023
Doctors say they’re on the cusp of offering the chance to return function to people living with spinal cord injuries, and the treatment will soon be available in Australia.
Posted on June 7th, 2022
Posted on January 15th, 2022
Keio University in Tokyo said Friday it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.
In the study commenced in December, the university will eventually transplant cells derived from iPS cells to four patients who between two to four weeks earlier lost motor and sensory function after sustaining injuries when playing sport or in traffic accidents.
Posted on January 12th, 2022
The company successfully used human implants for replacing the injured spinal cord of a living pig, thereby simulating the anticipated surgical procedure in humans.
Spinal cord injuries are notoriously difficult to operate on, but an Israeli biotech company has entered a new road on the way to a cure using pigs.